Evidence map›Paper›PMID 34399779›Full record

ArticleJournal of neuroinflammation2021

Microglia are involved in phagocytosis and extracellular digestion during Zika virus encephalitis in young adult immunodeficient mice.

William Enlow, Maude Bordeleau, Jocelyne Piret, Fernando González Ibáñez, Olus Uyar, Marie-Christine Venable, Nathalie Goyette, Julie Carbonneau, Marie-Eve Tremblay, Guy Boivin

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Chronic infection by atypicalBrain, behavior, & immunity - health · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Type I interferon receptor (Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

William Enlow *Centre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
Maude Bordeleau *Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada.
Jocelyne PiretCentre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.ORCID https://orcid.org/0000-0003-4102-0094
Fernando González IbáñezNeurosciences Axis, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
Olus UyarCentre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
Marie-Christine VenableCentre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
Nathalie GoyetteCentre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
Julie CarbonneauCentre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada.
Marie-Eve TremblayNeurosciences Axis, Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada. EveTremblay@uvic.ca.ORCID https://orcid.org/0000-0003-2863-9626
Guy BoivinCentre de Recherche en Infectiologie, Centre de Recherche du CHU de Québec-Université Laval, Quebec City, QC, Canada. Guy.Boivin@crchudequebec.ulaval.ca.ORCID http://orcid.org/0000-0003-3027-4662
Université Laval · CACentre hospitalier de l'Université Laval · CAUniversity of British Columbia · CAUniversity of Victoria · CA

Funding

CIHR 148361CIHR 353750Natural Sciences and Engineering Research Council of Canada RGPIN-2014-0508
6 · The paper itself

Abstract

backgroundZika virus (ZIKV) has been associated with several neurological complications in adult patients.

methodsWe used a mouse model deficient in TRIF and IPS-1 adaptor proteins, which are involved in type I interferon production, to study the role of microglia during brain infection by ZIKV. Young adult mice were infected intravenously with the contemporary ZIKV strain PRVABC59 (1 × 10

resultsInfected mice did not present overt clinical signs of the disease nor body weight loss compared with noninfected animals. However, mice exhibited a viremia and a brain viral load that were maximal (1.3 × 10

conclusionsThese results indicate that microglia are involved in the control of ZIKV replication and/or its elimination in the brain. After depletion of microglia, the removal of ZIKV-infected cells by phagocytosis could be partly compensated by astrocytes.

Indexed as

AnimalsBrainMiceMicrogliaNeuronsPhagocytosisZika Virus InfectionAstrocytesEncephalitisExtracellular digestionMicrogliaNeuroinflammationNeuronsPhagocytosisZika virus

Identifiers

PMID34399779
PMCPMC8369691
OpenAlexW3193558447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.